EQ
Equillium, Inc.
3.07
2 x 2.14
2 x 3.96
bid
ask
+
0.03
1.04%
09:51 AM
timesize
Ytd98.17%
1y859.91%
3.00
day range
3.06
0.29
52 week range
3.54
Open3.06Prev Close3.04Low3.00High3.06Mkt Cap190.94M
Vol12.99KAvg Vol678.03KEPS-0.21P/EN/AForward P/E-0.47
Beta1.83Short Ratio0.53Inst. Own20.04%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1150-d Avg2.53200-d Avg1.741yr Est3.33

EQ News

EQ Works Expands Multi-Year Partnership with Leading Canadian Publisher to Include SaaS License for ClearLake
accessnewswire.com
EQ Works Expands Multi-Year Partnership with Leading Canadian Publisher to Include SaaS License for

Three-year renewal follows early campaign results that delivered up to 40% increases in average orde

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LA JOLLA, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology in

Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammatory Disease Transcript
seekingalpha.com
Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammator

Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammator

Equillium Links AhR Activation to miR-124 as EQ504 Heads Toward Phase 1
marketbeat.com
Equillium Links AhR Activation to miR-124 as EQ504 Heads Toward Phase 1

Equillium NASDAQ: EQ Chief Scientific Officer Stephen Connelly outlined new preclinical data during

Equillium to Participate in the 2026 Jefferies Global Healthcare Conference
globenewswire.com
Equillium to Participate in the 2026 Jefferies Global Healthcare Conference

LA JOLLA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology inn

benzinga.com
Leerink Partners Upgrades Equillium to Outperform, Raises Price Target to $6

Leerink Partners analyst Thomas Smith upgrades Equillium (NASDAQ:EQ) from Market Perform to Outpe

Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis
globenewswire.com
Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (A

LA JOLLA, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology inn

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
Equillium Q1 EPS $(0.06) Misses $(0.05) Estimate

Equillium (NASDAQ:EQ) reported quarterly losses of $(0.06) per share which missed the analyst consen

Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights
globenewswire.com
Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights

Phase 1 proof-of-mechanism study of EQ504 on track to initiate in mid-2026, with data expected appro

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LA JOLLA, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology inn

Equiniti (EQ) Launches DealTrax™: A Digital-First Platform for Corporate Actions and M&A Events
globenewswire.com
Equiniti (EQ) Launches DealTrax™: A Digital-First Platform for Corporate Actions and M&A Events

DealTrax Highlights Include: Powerful Tools & Streamlined Processes: Quick, efficient deal setup wit

Equillium to Participate in Oppenheimer's 2026 Innovation on the Island Event
globenewswire.com
Equillium to Participate in Oppenheimer's 2026 Innovation on the Island Event

LA JOLLA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology i

benzinga.com
B. Riley Securities Initiates Coverage On Equillium with Buy Rating, Announces Price Target of $6

B. Riley Securities analyst William Woods initiates coverage on Equillium (NASDAQ:EQ) with a Buy

benzinga.com
Raymond James Initiates Coverage On Equillium with Strong Buy Rating, Announces Price Target of $6

Raymond James analyst Martin Auster initiates coverage on Equillium (NASDAQ:EQ) with a Strong Buy

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Aberdeen Group plc Grows Stake in Equillium, Inc. $EQ
defenseworld.net
Aberdeen Group plc Grows Stake in Equillium, Inc. $EQ

Aberdeen Group plc grew its holdings in Equillium, Inc. (NASDAQ: EQ) by 523.6% in the undefined quar

Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists
globenewswire.com
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Asso

LA JOLLA, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology i

benzinga.com
Cantor Fitzgerald Initiates Coverage On Equillium with Overweight Rating, Announces Price Target of

Cantor Fitzgerald analyst Emma Nealon initiates coverage on Equillium (NASDAQ:EQ) with a Overweig

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LA JOLLA, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology i

benzinga.com
Equillium Q4 EPS $(0.04) Beats $(0.14) Estimate

Equillium (NASDAQ:EQ) reported quarterly losses of $(0.04) per share which beat the analyst consensu

Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights
globenewswire.com
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clini

Initiation of Phase 1 proof-of-mechanism study of EQ504 planned for mid-2026, with data expected app

Equillium to Participate in the 38th Annual Roth Conference
globenewswire.com
Equillium to Participate in the 38th Annual Roth Conference

LA JOLLA, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology i

Christine Zedelmayer Sells 120,312 Shares of Equillium (NASDAQ:EQ) Stock
defenseworld.net
Christine Zedelmayer Sells 120,312 Shares of Equillium (NASDAQ:EQ) Stock

Equillium, Inc. (NASDAQ: EQ - Get Free Report) COO Christine Zedelmayer sold 120,312 shares of the s

benzinga.com
Roth Capital Initiates Coverage On Equillium with Buy Rating, Announces Price Target of $12

Roth Capital analyst Adam Walsh initiates coverage on Equillium (NASDAQ:EQ) with a Buy rating and

Equillium Announces $35 Million Financing with RA Capital Management
globenewswire.com
Equillium Announces $35 Million Financing with RA Capital Management

Capital strengthens the advancement of EQ504 through key clinical milestones Anticipated net proceed

Equillium: Multi-Cytokine Platform To Go Beyond Scope Of EQ504 For UC
seekingalpha.com
Equillium: Multi-Cytokine Platform To Go Beyond Scope Of EQ504 For UC

Equillium (EQ) remains a 'Hold' as it advances EQ504 for ulcerative colitis, with phase 1 trial init

Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference

LA JOLLA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology in

Short Interest in Equillium, Inc. (NASDAQ:EQ) Increases By 32.2%
defenseworld.net
Short Interest in Equillium, Inc. (NASDAQ:EQ) Increases By 32.2%

Equillium, Inc. (NASDAQ: EQ - Get Free Report) was the target of a large growth in short interest du

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Why Is Equillium Stock Soaring Monday?
benzinga.com
Why Is Equillium Stock Soaring Monday?

Equillium stock is trading higher Monday after the company announced up to $50 million in financing

benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

Gold Down Over 2%; Monday.com Shares Tumble After Q2 Results
benzinga.com
Gold Down Over 2%; Monday.com Shares Tumble After Q2 Results

US Stocks Mixed; Owens & Minor Posts Downbeat Earnings
benzinga.com
US Stocks Mixed; Owens & Minor Posts Downbeat Earnings

benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

benzinga.com
Equillium Announces Strategic Expansion To Integrate Cryptocurrency Treasury Reserve Strategy As Par

Equillium, Inc. (NASDAQ:EQ), a biotechnology innovator developing novel therapies to treat severe au

benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket

benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session